FDA Inspection 726129 — Ari-Med Pharmaceuticals

Ari-Med Pharmaceuticals — FEI 2027206

The FDA completed an inspection of Ari-Med Pharmaceuticals on May 23, 2011 in Tempe, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 23, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tempe, AZ (United States)